Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We are very pleased to announce that Sheraz Markar has been awarded the title of Associate Professor by the University of Oxford.

Associate Professor Sheraz Markar is an academic Oesophago-Gastric Surgeon and Co-deputy Director of the Surgical Interventional Trials Unit, Nuffield Department of Surgical Sciences (SITU NDS).

Associate Professor Sheraz MarkarAssociate Professor Markar qualified in Medicine from Cambridge University in 2007. He undertook his academic and surgical training in Cambridge, London and Oxford, including NIHR Doctoral Research and Clinical Trials Fellowship and NIHR Academic Clinical Lectureship. He has completed two PhD degrees, at Imperial College London developing a breath test for oesophago-gastric cancer and at Karolinska Institutet, Sweden, concerning complex statistical modelling of surgical outcomes from oesophagectomy. He has a strong academic and clinical interest in the management of benign and malignant upper gastrointestinal disease, with over 270 publications. He is a member and chair of several surgical committees including European Association of Endoscopic Surgery and European Society for Diseases of the Esophagus, and has received several research awards including the Royal College of Surgeons Hunterian Professorship 2020 and United European Gastroenterology Rising Star 2019. 

The focus of Associate Professor Markar’s research in Oxford is the design and implementation of challenging trials to improve the clinical outcomes for patients with oesophageal and gastric disease. He has recently received funding from the NIHR-HTA to undertake the largest international RCT concerning surveillance after oesophageal and gastric resection (SARONG trial), which will bring together a diverse team of researchers and clinicians to address this key clinical question.